Fibrogen Announces Passing of CEO Thomas B. Neff, Scientific Innovator and Pioneering Biopharmaceutical Executive
SAN FRANCISCO, Aug. 26, 2019 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ:FGEN) announced today that Thomas B. Neff, Chief Executive Officer and Chairman…
Name: Thomas B. Neff
Country: USA
Company: FibroGen, Inc.
Branch: Pharma
Position: CEO & Chairman
Reason: Dead
Announcement Date: August 25, 2019, 10:00pm